Ketamine abuse and apoptosis in the cortex in monkeys and mice by McAlonan, G et al.
Title Ketamine abuse and apoptosis in the cortex in monkeys andmice
Author(s) Li, Q; Wai, SP; Lam, WP; Yew, DT; McAlonan, G
Citation The 26th CINP Congress, Munich, Germany, 13-17 July 2008.
Issued Date 2008
URL http://hdl.handle.net/10722/126822
Rights Creative Commons: Attribution 3.0 Hong Kong License
236 Poster Sessions, Tuesday 15 July 2008
P-06.08 Tiagabine modulates the effect of cocaine sensitization on
a1-adrenoceptors
I. Nalepa1, M. Kowalska1, T. Witarski1, D. Nawrat1, A. Bielawski1, A. Roman1,
J. Vetulani1. 1Inst. of Pharmacology PAS, Brain Biochemistry, Krakow, Poland
Objective: Cocaine indirectly stimulates catecholaminergic systems and its
repeated administration sensitizes their responses. While interactions between
GABA-ergic and dopaminergic neurotransmission in a mechanism of cocaine
action were widely described, those concerning the noradrenergic system were
less explored. As we recently reported that the cocaine-induced behavioral
sensitization is accompanied by changes in the a1-adrenergic receptors (a1-ARs)
density in some regions of rat brain, we presently have investigated how those
effects are modulated by activation of GABA-ergic system – a procedure used
to depress symptoms of cocaine dependence.
Methods: To obtain cocaine sensitized rats (CSR) the animals received cocaine
(10 mg/kg) for 5 consecutive days (D1-D5), and remained drug-free for the
next four days (D6-D9). Cocaine naive rats (CNR) received saline. On D10
the rats were injected with saline or tiagabine (10 mg/kg) and after 120 min
received cocaine injection (10 mg/kg). They were decapitated 24 h later. The
cerebral a1-ARs density was measured by quantitative in vitro autoradiography
of [3H]prazosin in the absence (total a1-ARs) or presence of 10 nM WB4101
to dissect the a1B AR subtype.
Results: Tiagabine treatment decreased the total and a1B pools of a1-ARs in
structures involved in behavioral effects of cocaine: nucleus accumbens (NAc)
and primary motor cortex (M1), while it increased the a1B receptor in amygdala
and hippocampus. Cocaine in CNR increased a1B density in NAc and thalamus,
but sensitization abolished this effect. Cocaine decreased the total pool of a1-
ARs in cingulate and M1 of CNR, but this effect was also abolished in CSR.
On the other hand sensitization resulted in a decrease of a1-ARs in subcortical
areas – the thalamus, amygdala, and hippocampus, not observed in CNR. The
modulatory effect of tiagabine appeared in amygdala and hippocampus of CSR,
where tiagabine decreased a1B, and in NAc and amygdala, where tiagabine
annulled the effects of sensitization on the total pool of a1-ARs.
Conclusion: Tiagabine increased a1-ARs density in brain structures involved
in cocaine-induced aggressiveness and memory enhancement, while decreased
it in structures associated with reward and hypermotility. Effects induced by
cocaine in CNR were generally changed in opposite direction in CSR. Tiagabine
pretreatment attenuated the effects of cocaine sensitization on a1-ARs in NAc
and amygdala.
Supported by a grant 24/IV/2005 from POLPHARMA Foundation For Devel-
opment of Polish Pharmacy and Medicine.
P-06.09 Implication of dopamine D1A and D2 receptors in
hippocampus in the conditioning of the rewarding effect of
cocaine
T. Tanaka1, N. Hironaka1. 1JST, Shimojo Project, Kanagawa, Japan
Objective: The hippocampus is important for contextual conditioning. The
conditioned place preference (CPP) to drugs of abuse is a form of associative
process, thus it can be assumed to reflect hippocampal-dependent processes.
Dopamine is the one that has been more extensively implicated in the mechanism
of drug addiction. However, little if any is known about the functional and direct
implication of hippocampal dopamine receptors in the development of a cocaine-
induced rewarding effect. In the present study, we investigated whether dopamine
D1A and D2 receptors in hippocampus are implicated in the development of
cocaine-induced rewarding effect using a CPP paradigm in rats.
Methods: Rats were divided into four groups by session frequency: Group 0
underwent no conditioning session, pre- and post-test only; Group 1. underwent
pre-test, one pair of conditioning session (1 day for cocaine at 15 mg/kg, s.c.,
and 1 day for saline) and post-test; Group 2 underwent two pairs of conditioning
sessions once a day and Group 3 underwent three pairs of conditioning sessions
between pre- and post-test.
Results: Preference levels for the cocaine-associated box were frequency-
dependently increased. The mRNA of dopamine D1A and D2 receptors signifi-
cantly increased in the hippocampus of Group 2 only.
Conclusion: These results indicate that dopamine D1A and D2 receptors
in the hippocampus may be one of the critical mediators of the neuronal
changes necessary for the induction of this cocaine-induced rewarding effect.
The dynamic synaptic events regulated by neurotransmitters and their cognate
receptors underlie long-lasting changes that contribute to the intensity and
persistence of the drug in memory.
P-06.10 Vigabatrin and tiagabine abolish the expression of cocaine
sensitization
J. Vetulani1, A. Roman1, T. Witarski1, M. Kowalska1, M. Filip2, I. Nalepa1.
1Inst. of Pharmacology PAS, Brain Biochemistry, Krakow, Poland; 2Inst. of
Pharmacology PAS, Pharmacology, Krakow, Poland
Objective: Agents enhancing GABA transmission are very promising in treat-
ment of cocaine dependence. However, the results concerning clinical efficacy
of some of them, particularly of tiagabine, are discrepant. We investigated
therefore the effects of two compounds elevating GABA level: tiagabine (a
GABA reuptake inhibitor), and vigabatrin (a GABA transaminase inhibitor)
on expression of cocaine sensitization, a phenomenon regarded as indicative
of cocaine dependence.
Methods: Male Wistar rats weighing 230–270 g and housed 8 to a cage,
received in their home cages saline or cocaine (10 mg/kg) for 5 consecutive days
(D1-D5), and remained drug-free for the next four days (D6-D9), but on D8
were placed in Opto-Varimex cages for 45 min habituation and then injected with
saline and returned to the actometer for 60 min of activity recording. On D10 the
rats were placed in activity cages at −165 min, and injected with saline, vigabatrin
(75 or 150 mg/kg, or tiagabine (10 mg/kg) at −120 min for activity recording.
At time 0 min the rats were briefly removed from the cage for cocaine injection
(10 mg/kg) and immediately returned to the measuring device for recording motor
activity for 60 min. The activity was analyzed using Auto-track software. The
vehicle of gabergic drugs (0.5%Tween 80) was given at the corresponding times
to controls.
Results: Cocaine elevated the locomotor activity of naive mice approximately
14-fold (from 510±155 to 6,897±1,406 beam crosses per hour). Given to rats
receiving cocaine during days 1−5, cocaine produced an effect 2.2-fold stronger
(15,329±2,575). Pretreatment with both doses of vigabatrin or with tiagabine
brought down the cocaine-induced motor stimulation in sensitized animals
to the level observed after cocaine administration to cocaine-naive animals
(5,585±1,210, 7,735±1,696, and 7,843±1,430). The gabergic drugs used in the
same doses and time schedule did not inhibit the locomotor stimulation induced
by a single dose of cocaine in naive rats.
Conclusion: Clinical aspects of cocaine dependence are complex and possibly
not all of them are reflected in particular animal models. The present results
suggest that those aspects of cocaine dependence that undergo sensitization (e.g.,
paranoia and mood elevation, but not drug wanting) might be effectively reduced
by both vigabatrin and tiagabine.
Supported by a grant 24/IV/2005 from POLPHARMA Foundation For Devel-
opment of Polish Pharmacy and Medicine.
P-06.11 Ketamine abuse and apoptosis in the cortex in monkeys and
mice
L. Qi1, W. Sp2, L. Wp2, Y. Dt2, G. McAlonan3. 1The University of Hong Kong,
Dept. of Psychiatry, Hong Kong SAR, China; 2The CUHK, Dept. of Anatomy,
Hong Kong, Macao SAR, China; 3The University of Hong Kong, Dept. of
Psychiatry, Macao SAR, China
Objective: Ketamine, a noncompetitive antagonist at the glutamatergic
N-methyl-D-aspartate (NMDA) receptor, is currently used in human and animal
medicine as an injectable anesthetic. Ketamine is also a controlled substance,
illegally used as a recreational drug (“Special K”, “Vitamin K”). ketamine, as an
NMDA antagonist, can inhibit the reuptake of serotonin, dopamine, and nore-
pinephrine, although the mechanism underlying this action is not entirely clear.
There are, however, fewer evidences of the neurobiological or neurochemical
alterations according to symptoms of ketamine abuse. No evidence shows the
long-term effects in young adults with ketamine abuse. Therefore in the present
study, we attempt to examine whether apoptosis is a potential mechanism for the
ketamine abuse-related loss of function in the brain (in particular the cortex).
Caspases-dependent pathway is one of the most studied apoptosis pathways.
Activation of the caspase-9, which in turn activates caspase-3, is a central
pathway for apoptosis. Caspase-6 is activated for fragmentation of the nucleus,
which leads to downstream events of apoptosis. In addition, we try to use
functional magnetic resonance imaging (fMRI) to explore the neuronal activities
in cortical and subcortical brain areas in the ketamine abuse animal model.
Methods: Establish long-term ketamine abuse models in Cynomologus Mon-
keys (1 mg/kg i.v. ketamine for 14 days) and in mice (1 mg/kg i.p. Ketamine for
14 days). Test neuronal activities and metabolism in ketamine abuse monkeys by
using fMRI. In this study, we raised the monkey’s right legs during the stimulation
periods under fMRI. Investigate protein levels of pro-apoptotic (caspase-3, -6
and -9) in the cortex in ketamine abused mice by using western blotting.
Results: It is interesting to find an obviously decreased blood oxygenation
level dependent (BOLD) signal of the sensation area in the cortex in Ketamine
abused monkeys (see Figure 1 and 2). The expression of caspase-3 and -9
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significantly increases in the cortex of the ketamine abused mice, however, there
is no difference of caspase-6 expression in the cortex in the ketamine abused
mice.
Figures 1,2. fMRI studies of the cortex in monkeys. In this study, we moved the
monkeys’ right legs up and down 5 times during the stimulation periods under
fMRI. The white arrow indicates the sensation area of the cortex for the response
of leg movements; figure 1: monkeys administered vehicle for 14 days; figure 2:
monkeys administered 1 mg/kg ketamine for 14 days.
Conclusion: Administration of ketamine for long time could decrease neuronal
activities. Caspases-dependent apoptosis in central nervous system (CNS) may
involve in this alteration. But further relations between caspases-dependent apop-
tosis and neuronal activities in ketamine abuse models need to be investigated.
P-06.12 Expression of mRNA for corticoliberin and vasopressin in
hypothalamus and amygdala of rats following administration
of psychoactive drugs
P. Shabanov1, A. Lebedev1. 1Military Medical Academy, Pharmacology, St.
Petersburg, Russia
Objective: The purpose was to evaluate the expression of mRNA for cor-
ticoliberin and vasopressin in hypothalamus and amygdala of rats following
administration of psychoactive drugs.
Methods: Wistar rats were injected intraperitoneally within 4 days in el-
evated doses with: 1) physiological saline (control; 0.1−0.2−0.4−0.8 ml/rat),
2) amphetamine (0.5–1.0–2.0–4.0 mg/kg); 3) fentanyl (0.00625–0.0125–0.025–
0.05 mg/kg), 4) ethanol 40% solution (0.5–1.0–2.0–4.0 g/kg), 5) sodium etham-
inal (2.5–5-10–20 mg/kg) or 6) dexa-methasone (0.5–1.0–2.0–4.0 mg/kg). The
forced regimen of drug administration led to gradual load of the organism and
prevented drug tolerance. This method was actively used for formation of drug
dependence (or its features) from different narcogens.
Results: The biggest mRNA expression for corticoliberin was registered in
amygdala after administration of dexamethasone (0.46 units compared with b-
actin), and the minimal one was after sodium ethaminal (0.07) and fentanyl
(0.037). In hypothalamus, sodium ethaminal produced the elevated mRNA ex-
pression (0.8 unit), then were ethanol (0.37) and fentanyl (0.039). Amphetamine
did not activate mRNA expression for corticoliberin nor in hypothalamus, nor
in amygdala for all of the drugs studied. The mRNA expression for vasopressin
did not register for all drugs both in hypothalamus and amygdala.
Conclusion: Therefore, the reinforcing system of hypothalamus supports the
typical reaction on narcogens administration, where as the extended amygdala
includes both the proper reinforcement and stress reactivity elements.
P-06.13 Ultra-low dose opioid antagonist naltrexone potentiates
cannabinoid anticonvulsant effects in the pentylenetetrazole-
induced seizure in mice
A. Bahremand1, S. Ebrahimi Nasrabady1, H. Shafaroodi2, M. Ghasemi1,
S. Gholizadeh3, A.R. Dehpour1. 1University of Medical Sciences, Dept. of
Pharmacology, Tehran, Islamic Republic of Iran; 2Azad University, Dept. of
Pharmacology, Tehran, Islamic Republic of Iran; 3University of Medical Sci-
ences, Pharmacy, Tehran, Islamic Republic of Iran
Objective: It is widely accepted that cannabinoid compounds are anticonvulsant
since they have inhibitory effects at micromolar doses, which are mediated by
activated receptors coupling to Gi/o proteins. Surprisingly, both the analgesic and
anticonvulsant effects of opioids are enhanced by ultra-low doses (nanomolar to
picomolar) of the opioid antagonist naltrexone and as opioid and cannabinoid
systems interact, it has been shown that ultra-low dose naltrexone also enhances
cannabinoid-induced antinociception. Concerning the seizure modulating prop-
erties of both classes of receptors, this study investigated whether the ultra-low
dose opioid antagonist naltrexone influences cannabinoid anticonvulsant effects.
Methods: The clonic seizure threshold was tested in separate groups of male
NMRI mice following injection of vehicle, the cannabinoid selective agonist
arachidonyl-2-chloroethylamide (ACEA) and ultra-low doses of the opioid re-
ceptor antagonist naltrexone and a combination of ACEA and naltrexone doses
in a model of clonic seizure induced by pentylenetetrazole (PTZ).
Results: Systemic administration of ultra-low doses of naltrexone
(1 pg/kg-1 ng/kg, i.p.) significantly potentiated the anticonvulsant effect of ACEA
(1 mg/kg, i.p.). Moreover, the very low dose of naltrexone (0.5 ng/kg) unmasked
a strong anticonvulsant effect for very low doses of ACEA (10 and 100 mg/kg).
A similar potentiation by naltrexone (0.5 ng/kg) of anticonvulsant effects of non-
effective dose of ACEA (1 mg/kg) was also observed in the generalized tonic-
clonic model of seizure.
Conclusion: The present data indicate that the interaction between opioid
and cannabinoid systems extends to ultra-low dose levels and ultra-low doses of
opioid receptor antagonist in conjunction with very low doses of cannabinoids
may provide a potent strategy to modulate seizure susceptibility.
P-06.14 The effects of ascorbic acid on morphine withdrawal symptoms
in rats
A. Alijarahi. Qazvin Azad University, Physiology, Islamic Republic of Iran
Objective: Recent studies indicate that the glutamatergic and Dopaminergic
systems are also involved in morphine tolerance and dependence on morphine
and in morphine withdrawal syndrome. Ascorbic acid (ascorbate) which is
an antioxidant vitamin released from glutamatergic neurons and modulate the
synaptic action of dopamine and glutamate as well as behavior. Since Ascorbate
modulate the synaptic action of dopamine and glutamate, in this study the effect
of Ascorbate on morphine withdrawal syndrome in rats has been investigated.
Objective: to determine the effects of Ascorbic acid on morphine withdrawal
syndrome.
Methods: 30 Male rats (250–300gr) were tested in this study in two groups.
The first group as the control group recived 3% sucrose in tap water(n = 6)
and the second group as the dependent group recived morphine (0.1, 0.2, 0.3,
0.4 mg/ml each one for 48h, and 0.4 mg/ml remining days to 21th days) and 3%
sucrose in tap water (n = 24), this group divided in to 4 sub groups: (1) morphine
group, (2,3,4) morphine-Ascorbic acid groups which received AA (100, 500,
1000 mg/kg I.P) every 48 h and in the end (21th day) 30 min befor naloxone
administration for evaluation effects of AA on withdrawal signs.
Results: Our results show that: Ascorbate (100, 500, 1000 mg/kg I.P) can
greatly attenuate most of morphine withdrawal syndrome (but not all) dose
dependently.
P-06.15 Sigma-1 receptor chaperones at the ER regulate dendritic
arborization and NMDA/AMPA receptor anchorings in
primary hippocampal neurons
T.-P. Su1, S.-Y. Tsai1, T. Hayashi1. 1NIDA-NIH, Cellular Pathobiology Section,
Baltimore, USA
Objective: To examine if the sigma-1 receptor chaperone at the endoplasmic
reticulum may regulate the development and maturation of dendrites and the
anchorings of NMDA/AMPA receptors in developing neurons.
